drug
pindolol
Marketedupdated 3mo agoby Nostrum Pharmaceuticals LLC
Approvedcommunity read0 votes
indications
investigational
Hypertension
all catalysts(0)
nothing on the calendar yet
Trials studying pindolol
News(1)
- Actimed gets back rights to wasting disease drug, ending $126M deal with FaradayActimed Therapeutics has brought the full rights to its wasting disease drug back in-house, securing “strategic control” over the asset but losing out on a shot at over $120 million in biobucks.fiercebiotech · 8d ago
Data sources
last refreshed 48m ago
Found something off?
comments(0)
5-min edit window · permanent after that